Protein denaturation induced by cyclic silicone

Biomaterials

Volumn 18, Issue 24, 1997, Pages 1593-1597

  Sun, Linfeng ^a   Alexander, Harold ^a,b   Lattarulo, Nina ^a   Blumenthal, Normam C ^a   Ricci, John L ^a   Chen, Guo Gang ^a  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b Orthogen Corporation   (United States)

Author keywords

Breast implant; Cyclic silicone; Fibrinogen; Fibronectin; Protein conformation; Protein denaturation

Indexed keywords

BIOMATERIALS; FLUORESCENCE; IMPLANTS (SURGICAL); SILICONES;

BREAST IMPLANT; CYCLIC SILICONE; DENATURATION; FIBRINOGEN; FIBRONECTIN;

PROTEINS;

FIBRINOGEN; FIBRONECTIN; SILICONE; TRYPTOPHAN;

ARTICLE; BREAST ENDOPROSTHESIS; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; FLUORESCENCE; IMMUNE RESPONSE; MOLECULAR WEIGHT; PRECIPITATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DENATURATION;

ADJUVANTS, IMMUNOLOGIC; CIRCULAR DICHROISM; FIBRINOGEN; FIBRONECTINS; PRECIPITATION; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN STRUCTURE, TERTIARY; SILOXANES; SPECTROMETRY, FLUORESCENCE; TRYPTOPHAN;

EID: 0031411971     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(97)00105-1     Document Type: Article

References (25)

1. 1. Kossovsky, N., Zeidler, M., Chun, G. et al., Surface dependent antigens identified by high binding avidity of serum antibodies in a subpopulation of patients with breast prostheses. J. Appl. Biomater., 1993, 4, 281-288.
2. 2. Kossovsky, N. Silicone Science, 1995, Vol. 1, SBI Laboratories, p. 3.
3. 3. Boley, W. F. and LeVier, R. R., lmmunological enhancing activities of organosilicone compounds and non-functional fluids. Dow Corning Internal Study, October 1974.
4. 4. Kendrick, T. C., Parbhoo, B. M. and White, J. W., Polymerization of cyclosiloxanes. In Comprehensive Polymer Science, Vol. 4, Chain Polymerization II, ed. G. C. Eastmond, A. Ledwith, S. Russo and P. Sigwalt, Pergamon Press, New York, 1990, pp. 459-523.
5. 5. Carmichael, J. B. and Winger, R., Cyclic distribution in dimethylsiloxanes. J. Polym. Sci.: Part A, 1965, 3, 971-981.
6. 6. Carmichael, J. B., Gordon, D. J. and Ferguson, C. E., Analysis of large linear and cyclic methylsiloxanes and computer calculation of the chromatographic data. J. Gas Chromotogr., September 1966, 4, 347-349.
7. 7. Nakamura, K., Refojo, M. F., Crabtree, D. V. and Leong, F.-L, Analysis and fractional ion of silicone and fluorosilicone oils for intraocular use. Invest. Ophthalmol. Visual Sci., 1990, 31, 2059-2069.
8. 8. Wilkerson, R., General silicone chemistry. Distributed communication to FDA Advisory Panel, February 1992.
9. 9. Batich, C., Silicone degradation reactions. Abstract, Immunology of Silicones Workshop, 13-14 March 1995, NIH, Bethesda, MD, p. 5.
10. 10. Kossovsky, N. and Freiman, C. J., Immunology of silicone breast implants. J. Biomater. Appl., 1994, 8, 237-246.
11. 11. Vojdani, A., Bautbar, N. and Campbell, A. W., Antibody to silicone and native macromolecules in women with silicone implants. Immunopharmacol. Immunotoxicol., 1994, 16, 497-523.
12. 12. Devlin, T. M., ed., Biochemistry, Wiley-Liss, New York, 1992.
13. 13. Hynes, R. O. and Yamada, K. M., Fibronectins: multifunctional modular glycoproteins. J. Cell Biol., 1982, 95, 369-377.
14. 14. Furlan, M., Structure of fibrinogen and fibrin. In Fibrinogen, Fibrin Stabilisation and Fibrinolysis: Clinical Biochemical and Laboratory Aspects, ed. J. L. Francis, Chichester, 1988, pp. 17-64.
15. 15. Pearlstein, E., Gold, L. I. and Garcia-Pardo, A., Fibronectin: a review of its structure and biological activity. Mol. Cell Biochem., 1980, 29, 103-128.
16. 16. Ruoslahti, E., Engvall, E. and Hayman, E. G. Fibronectin: current concepts of its structure and functions. Coll Res., 1981, 1, 95-128.
17. 17. Yamada, K. M., Biochemistry of fibronectin. In The Glycococonjugates, Vol. III, Glycoprotein, Glycolipids, and Proteoglycans, Part A, ed. M.I. Horowitz, Academic Press, New York, 1982, pp. 331-362.
18. 18. Tan, J. S. and Martic, P. A., Protein adsorption and conformational change on small polymer particles. J. Coll. Interface Sci., 1990, 136, 415-431.
19. 19. Ohta, N. and Totsuyanagi, T., Alteration of fibrinogen secondary structure by cis-diaminedichloroplatinum(II) and calcium protection. Biol. Pharm. Bull., 1993, 16, 631-634.
20. 20. Brumfeld, V. and Werber, M. M., Studies on fibronectin and its domains. Arch. Biochem. Biophys., 1993, 302, 134-143.
21. 21. Freilder, D., ed., Physical Biochemistry: Applications to Biochemistry and Molecular Biology, Freeman, San Francisco, 1976, pp. 410-443.
22. 22. Alexander, S. S. Jr., Colonna, G. and Edelhoch, H., The structure and stability of human plasma cold-insoluble globulin. J. Biol. Chem., 1979, 254, 1501-1505.
23. 23. Williams, E. G., Janmey, P. A., Ferry, J. D. and Mosher, D. F., Conformational states of fibronectin. Effects of pH, ionic strength, and collagen binding, J. Biol. Chem., 1982, 257, 14973-14978.
24. 24. Lackowicz, J, R., ed., Principles of Fluorescence Spectroscopy, Plenum Press, New York, 1983, pp. 342-381.
25. 25. Chen, S. S., Chittur, K. K., Sukenik, C. N., Gulp, L. A. and Lewandowska, K., The conformation of fibronectin on self-assembled monolayers with different surface composition: an FTIR/ATR study. Trans. Soc. Biomater., 1993, 16, 308.